Margaret L. Wilsher

Auckland, AUK, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statement.

Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statement.

Journal: The European respiratory journal

Published: September 17, 2025

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry.

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry.

Journal: Internal medicine journal

Published: August 21, 2025

Pharmaco-economic Inequalities in Access to Antifibrotic Treatment for Interstitial Lung Disease in the Asia-Pacific Region.

Pharmaco-economic Inequalities in Access to Antifibrotic Treatment for Interstitial Lung Disease in the Asia-Pacific Region.

Journal: Tuberculosis and respiratory diseases

Published: March 27, 2025

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease.

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease.

Journal: Thorax

Published: April 18, 2024

Quantitative Analysis of Lung Shape in Idiopathic Pulmonary Fibrosis: Insights Into Disease- and Age-Associated Patterns.

Quantitative Analysis of Lung Shape in Idiopathic Pulmonary Fibrosis: Insights Into Disease- and Age-Associated Patterns.

Journal: Academic radiology

Published: December 12, 2023

Evaluating Tissue Heterogeneity in the Radiologically Normal-Appearing Tissue in IPF Compared to Healthy Controls.

Evaluating Tissue Heterogeneity in the Radiologically Normal-Appearing Tissue in IPF Compared to Healthy Controls.

Journal: Academic radiology

Published: July 20, 2023

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.

Journal: Respirology (Carlton, Vic.)

Published: June 02, 2023

Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.

Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.

Journal: Chest

Published: November 01, 2022

Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged > 50 years.

Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged > 50 years.

Journal: Scientific reports

Published: October 15, 2022

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.

Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.

Journal: Thorax

Published: July 11, 2022

Friend or foe? Corticosteroids in sarcoidosis.

Friend or foe? Corticosteroids in sarcoidosis.

Journal: Respirology (Carlton, Vic.)

Published: January 16, 2022

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions.

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions.

Journal: Pulmonary circulation

Published: June 13, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026